Patent 7820815 was granted and assigned to Boehringer Ingelheim on October, 2010 by the United States Patent and Trademark Office.
The invention relates to an improved process for preparing enantiomerically pure 8-(3-aminopiperidin-1-yl)-xanthines. The process involves reacting a compound of the formula (III) with 3-(phthalimido)piperidine or an enantiomer thereof